Stock market today: S&P 500 drops for fifth day as focus shifts to Powell’s speech
DENVER - DaVita Inc . (NYSE:DVA) reported fourth quarter earnings that beat analyst expectations, but shares tumbled 6.9% after the dialysis provider issued weaker-than-expected guidance for 2025.
The company posted adjusted earnings per share of $2.24 for Q4, surpassing the analyst consensus of $2.13. Revenue came in at $3.3 billion, also topping estimates of $3.26 billion.
However, DaVita’s outlook for 2025 fell short of Wall Street projections. The company forecast full-year EPS of $10.20 to $11.30, below the $11.44 analysts were expecting on average.
"Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range," said CEO Javier Rodriguez.
For Q4, DaVita reported consolidated revenues of $3.295 billion, up from $3.146 billion a year earlier. U.S. dialysis patient service revenues rose to $2.881 billion from $2.765 billion in Q4 2023.
The company said it provided dialysis services to approximately 281,100 patients at 3,166 outpatient centers as of December 31, 2024.
DaVita repurchased 2.3 million shares of its common stock for $367 million during the fourth quarter at an average price of $156.46 per share.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.